Cargando…

Persistent hepatic IFN system activation in HBV-HDV infection determines viral replication dynamics and therapeutic response

Hepatitis delta virus (HDV), a satellite virus of HBV, is regarded as the most severe type of hepatitis virus because of the substantial morbidity and mortality. The IFN system is the first line of defense against viral infections and an essential element of antiviral immunity; however, the role of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chida, Takeshi, Ishida, Yuji, Morioka, Sho, Sugahara, Go, Han, Christine, Lam, Bill, Yamasaki, Chihiro, Sugahara, Remi, Li, Meng, Tanaka, Yasuhito, Liang, T. Jake, Tateno, Chise, Saito, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243812/ https://www.ncbi.nlm.nih.gov/pubmed/37154158 http://dx.doi.org/10.1172/jci.insight.162404

Ejemplares similares

Early Multiphasic HBV Infection Initiation Kinetics Is Not Clone-Specific and Is Not Affected by Hepatitis D Virus (HDV) Infection
por: Tsuge, Masataka, et al.
Publicado: (2019)

Estimating Drug Efficacy with a Diet-Induced NASH Model in Chimeric Mice with Humanized Livers
por: Kisoh, Keishi, et al.
Publicado: (2021)

Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency
por: Sugahara, Go, et al.
Publicado: (2020)

Transmission of HBV DNA Mediated by Ceramide-Triggered Extracellular Vesicles
por: Sanada, Takahiro, et al.
Publicado: (2016)

HBV and HDV: New Treatments on the Horizon
por: Zuccaro, Valentina, et al.
Publicado: (2021)

The whole transcriptome effects of the PPARα agonist fenofibrate on livers of hepatocyte humanized mice
por: de la Rosa Rodriguez, Montserrat A., et al.
Publicado: (2018)

Chances for cure in chronic HBV/HDV coinfection
por: Iliescu, Gabriela, et al.
Publicado: (2014)

Hepatitis Delta Virus: HDV-HBV Interactions
por: Sureau, Camille
Publicado: (2006)

Chimeric Mice with Humanized Livers: A Unique Tool for in Vivo and in Vitro Enzyme Induction Studies
por: Kakuni, Masakazu, et al.
Publicado: (2013)

Long‐term cell fate and functional maintenance of human hepatocyte through stepwise culture configuration
por: Sugahara, Go, et al.
Publicado: (2023)

Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV
por: Mateo, Roberto, et al.
Publicado: (2023)

Anti-HDV seroprevalance among patients with previous HBV infection
por: Sahin, Abdurrahman, et al.
Publicado: (2018)

Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice
por: Giersch, Katja, et al.
Publicado: (2017)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
por: Hartl, Janine, et al.
Publicado: (2012)

Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients
por: Schmidbauer, Caroline, et al.
Publicado: (2021)

Key Factors for “Fishing” NTCP as a Functional Receptor for HBV and HDV
por: Yan, Huan, et al.
Publicado: (2023)

Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection
por: Costante, Federico, et al.
Publicado: (2023)

Inhibitory Effect of IL-1β on HBV and HDV Replication and HBs Antigen-Dependent Modulation of Its Secretion by Macrophages
por: Delphin, Marion, et al.
Publicado: (2021)

HDV-Like Viruses
por: Pérez-Vargas, Jimena, et al.
Publicado: (2021)

True prevalence of twin HDV-HBV infection in Pakistan: a molecular approach
por: Khan, Asad U, et al.
Publicado: (2011)

The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation
por: Battistella, Sara, et al.
Publicado: (2023)

Evaluation of miR-222 Expression in HBV Infected Patients in Comparison with HDV and HBV Co-infected Patients
por: Sokhanvar, Zahra, et al.
Publicado: (2021)

HBV/HDV Co-Infection: Epidemiological and Clinical Changes, Recent Knowledge and Future Challenges
por: Sagnelli, Caterina, et al.
Publicado: (2021)

Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis
por: Hoan, Nghiem Xuan, et al.
Publicado: (2021)

Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening
por: Kirstgen, Michael, et al.
Publicado: (2021)

IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection
por: Palatini, Massimo, et al.
Publicado: (2022)

Discontinuation of Passive Immunization Is Safe after Liver Transplantation for Combined HBV/HDV Infection
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2021)

Insight into the Contribution and Disruption of Host Processes during HDV Replication
por: Goodrum, Gabrielle, et al.
Publicado: (2018)

HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection
por: Bazinet, Michel, et al.
Publicado: (2022)

HDV+HBV hepatitis reactivation due to immunossuppressive therapy for hematological malignancies – an increasingly complex challenge
por: Molagic, Violeta, et al.
Publicado: (2013)

Culture density contributes to hepatic functions of fresh human hepatocytes isolated from chimeric mice with humanized livers: Novel, long-term, functional two-dimensional in vitro tool for developing new drugs
por: Yamasaki, Chihiro, et al.
Publicado: (2020)

Isolation and Characterization of Highly Replicable Hepatitis C Virus Genotype 1a Strain HCV-RMT
por: Arai, Masaaki, et al.
Publicado: (2013)

HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets
por: Colagrossi, Luna, et al.
Publicado: (2018)

PCR-Based Molecular Diagnosis of Hepatitis Virus (HBV and HDV) in HCV Infected Patients and Their Biochemical Study
por: Riaz, Muhammad Nasir, et al.
Publicado: (2016)

Poor clinical and virological outcome of nucleos(t)ide analogue monotherapy in HBV/HDV co-infected patients
por: Scheller, Laura, et al.
Publicado: (2021)

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection
por: Burm, Rani, et al.
Publicado: (2022)

Detection of acute toxicity of aflatoxin B1 to human hepatocytes in vitro and in vivo using chimeric mice with humanized livers
por: Ishida, Yuji, et al.
Publicado: (2020)

Hepatitis D, B and C virus (HDV/HBV/HCV) coinfection as a diagnostic problem and therapeutic challenge
por: Lorenc, Beata, et al.
Publicado: (2017)

AAV-HDV: An Attractive Platform for the In Vivo Study of HDV Biology and the Mechanism of Disease Pathogenesis (†)
por: Maestro, Sheila, et al.
Publicado: (2021)

Circulation of HDV Genotypes in Brazil: Identification of a Putative Novel HDV-8 Subgenotype
por: Mello, Francisco C. A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hpaa4qrg2t7hc68mhc09ro7dhe